Lexagene Holdings Inc V.LXG

Primary Symbol: LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > 2 Covid vaccines ready by Christmas

<< Previous

Bullboard Posts

Next >>

Comment by Investor62on Nov 05, 2020 9:27am

39 Views

Post# 31841256

RE:Re: 2 Covid vaccines ready by Christmas

It is so boring to read your (letsoit) irrelevant posts. Even with a COVID vaccination you need MiQLab. COVID has a $ 6B market size - Lexange target markets is about $ 60B.

Thank you in advance for the answer that I am an idiot - I wouldn't expect more from you, so no need to reply.

<< Previous

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports